trump glp-1 medicaid Pres. Donald announced that starting July 1, 2026, Medicare patients will be able to access weight-loss medications such as Ozempic for a $50 monthly copay through a new short-term Centers JUST IN: The Trump administration

Diabetes care 42 (9), 17241732

Continuous chromatography For all the promise of emerging upstream innovations, the impact of these innovations on overall throughput may be limited by downstream inefficienciesespecially when it comes to batch chromatography, which is a time- and space-intensive operation in the peptide manufacturing lifecycle

A portion of users report appetite changes, while just as many say they saw no noticeable difference

Even under identical caloric prescriptions, semaglutide produced a 16.0 % weight loss by week 68 compared to 8.0 % with placebo, further supporting the additive pharmacologic effects of GLP-1 therapies beyond dietary and physical activity adherence

The vial needs to be refrigerated upon arrival and stored properly to maintain potency

Weight management in this population should be approached with lifestyle changes and under the guidance of healthcare providers experienced in pediatric obesity management